Back to Journals » Clinical Ophthalmology » Volume 15

Ripasudil Endgame: Role of Rho-Kinase Inhibitor as a Last-Ditch-Stand Towards Maximally Tolerated Medical Therapy to a Patient of Advanced Glaucoma

Total article views   HTML views PDF downloads Totals
6,664 Dovepress* 6,071+ 493 6,564
PubMed Central* 593 107 700
Totals 6,664 600 7,264
*Since 24 June 2021
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar